The Oncology Institute, Inc. (TOI)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Patient Services	213.50M	Log In	Log In
Patient Services Growth	28.01%	Log In	Log In
Dispensary	103.84M	Log In	Log In
Dispensary Growth	30.87%	Log In	Log In
Clinical Trials & Other	6.90M	Log In	Log In
Clinical Trials & Other Growth	8.58%	Log In	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States	324.24M	Log In	Log In
United States Growth	28.42%	Log In	Log In